ArticleScientific reports2025
CT-based intratumoral heterogeneity quantification fusing deep learning radiomics for predicting lymph node metastasis in early-stage lung adenocarcinoma: a multicenter study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodal radiomics incorporating intratumoral heterogeneity for prognostic assessment of metastatic outcomes in invasive breast cancer.Breast cancer research : BCR · 2026Article
- An integrated prognostic model incorporating clinical characteristics, multiparametric MRI radiomics, deep learning features, and intratumoral heterogeneity for glioma patients.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This multicenter study aims to quantified CT-based intratumoral heterogeneity (ITH) and provide a novel valuable dimension for deep learning radiomics in predicting lymph node metastases (LNM) in early-stage lung adenocarcinoma (LUAD). Data from 787 early-stage LUAD patients who underwent surgery were retrospectively analyzed across three centers. By unsupervised clustering CT tumor 2D subregions, the ITHscore was generated. A fusion predictive model incorporating the deep learning features, Radscore and ITHscore was developed and validated. ITHscore was an important predictor achieved AUCs of 0.813, 0.807, 0.718 in test sets, respectively. Gene Set Enrichment Analysis of the test dataset D revealed the epithelial-mesenchymal transition pathway as the top enriched gene signature (NES = 1.71, p < 0.001) in the high ITHscore group. The fusion model demonstrated the best prediction performance, with AUCs of 0.832, 0.884, and 0.815 in test sets. Correlation and interpretability analyses confirmed that these three feature sets from different dimensions have a good synergistic effect in capturing imaging phenotypes. The ITHscore can be used as a novel imaging biomarker for predicting LNM in early-stage LUAD. The deep learning radiomics model fusing the ITHscore provided new insights for promoting the early non-invasive personalized treatment of LUAD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.